These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10645926)

  • 1. Inhibition of late vein graft neointima formation in human and porcine models by adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-3.
    George SJ; Lloyd CT; Angelini GD; Newby AC; Baker AH
    Circulation; 2000 Jan; 101(3):296-304. PubMed ID: 10645926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of tissue inhibitor of metalloproteinase-1, -2, and -3 during neointima formation in organ cultures of human saphenous vein.
    Kranzhöfer A; Baker AH; George SJ; Newby AC
    Arterioscler Thromb Vasc Biol; 1999 Feb; 19(2):255-65. PubMed ID: 9974405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained reduction of vein graft neointima formation by ex vivo TIMP-3 gene therapy.
    George SJ; Wan S; Hu J; MacDonald R; Johnson JL; Baker AH
    Circulation; 2011 Sep; 124(11 Suppl):S135-42. PubMed ID: 21911803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene transfer of the urokinase-type plasminogen activator receptor-targeted matrix metalloproteinase inhibitor TIMP-1.ATF suppresses neointima formation more efficiently than tissue inhibitor of metalloproteinase-1.
    Lamfers ML; Grimbergen JM; Aalders MC; Havenga MJ; de Vries MR; Huisman LG; van Hinsbergh VW; Quax PH
    Circ Res; 2002 Nov; 91(10):945-52. PubMed ID: 12433840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentially positive ageing-related variations of medial smooth muscle cells in the saphenous veins used as aortocoronary bypass grafts.
    Perek B; Malinska A; Gasowski J; Ostalska-Nowicka D; Perek A; Jemielity M; Zabel M; Nowicki M
    Folia Histochem Cytobiol; 2016; 54(2):91-98. PubMed ID: 27845500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pressure distention compared with pharmacologic relaxation in vein grafting upregulates matrix metalloproteinase-2 and -9.
    Chung AW; Rauniyar P; Luo H; Hsiang YN; van Breemen C; Okon EB
    J Vasc Surg; 2005 Oct; 42(4):747-56. PubMed ID: 16242564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene transfer of tissue inhibitor of metalloproteinase-2 inhibits metalloproteinase activity and neointima formation in human saphenous veins.
    George SJ; Baker AH; Angelini GD; Newby AC
    Gene Ther; 1998 Nov; 5(11):1552-60. PubMed ID: 9930309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo suppression of vein graft disease by nonviral, electroporation-mediated, gene transfer of tissue inhibitor of metalloproteinase-1 linked to the amino terminal fragment of urokinase (TIMP-1.ATF), a cell-surface directed matrix metalloproteinase inhibitor.
    Eefting D; de Vries MR; Grimbergen JM; Karper JC; van Bockel JH; Quax PH
    J Vasc Surg; 2010 Feb; 51(2):429-37. PubMed ID: 20036101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stent-based delivery of tissue inhibitor of metalloproteinase-3 adenovirus inhibits neointimal formation in porcine coronary arteries.
    Johnson TW; Wu YX; Herdeg C; Baumbach A; Newby AC; Karsch KR; Oberhoff M
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):754-9. PubMed ID: 15681295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term exposure to thapsigargin inhibits neointima formation in human saphenous vein.
    George SJ; Johnson JL; Angelini GD; Jeremy JY
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2500-6. PubMed ID: 9409220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of p53 increases lumen size and blocks neointima formation in porcine interposition vein grafts.
    Wan S; George SJ; Nicklin SA; Yim AP; Baker AH
    Mol Ther; 2004 May; 9(5):689-98. PubMed ID: 15120330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of smooth muscle cell migration and neointima formation in vein grafts by overexpression of matrix metalloproteinase-3.
    Kallenbach K; Salcher R; Heim A; Karck M; Mignatti P; Haverich A
    J Vasc Surg; 2009 Mar; 49(3):750-8. PubMed ID: 19268777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of endothelin-1 (ET) receptors (ET(A) and ET(B)) and immunoreactive ET-1 in porcine saphenous vein-carotid artery interposition grafts.
    Dashwood MR; Mehta D; Izzat MB; Timm M; Bryan AJ; Angelini GD; Jeremy JY
    Atherosclerosis; 1998 Apr; 137(2):233-42. PubMed ID: 9622266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of matrix metalloproteinase activity in human saphenous vein grafts using adenovirus-mediated gene transfer.
    Fernandez HA; Kallenbach K; Seghezzi G; Mehrara B; Apazidis A; Baumann FG; Grossi EA; Colvin S; Mignatti P; Galloway AC
    Surgery; 1998 Aug; 124(2):129-36. PubMed ID: 9706130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The endothelin 1A receptor antagonist BSF 302146 is a potent inhibitor of neointimal and medial thickening in porcine saphenous vein-carotid artery interposition grafts.
    Wan S; Yim AP; Johnson JL; Shukla N; Angelini GD; Smith FC; Dashwood MR; Jeremy JY
    J Thorac Cardiovasc Surg; 2004 May; 127(5):1317-22. PubMed ID: 15115988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-mediated gene transfer of fibromodulin inhibits neointimal hyperplasia in an organ culture model of human saphenous vein graft disease.
    Ranjzad P; Salem HK; Kingston PA
    Gene Ther; 2009 Sep; 16(9):1154-62. PubMed ID: 19474808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased secretion of basement membrane-degrading metalloproteinases in pig saphenous vein into carotid artery interposition grafts.
    Southgate KM; Mehta D; Izzat MB; Newby AC; Angelini GD
    Arterioscler Thromb Vasc Biol; 1999 Jul; 19(7):1640-9. PubMed ID: 10397681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular matrix and vein graft failure. Is the message in the medium?
    Loscalzo J
    Circulation; 2000 Jan; 101(3):221-3. PubMed ID: 10645913
    [No Abstract]   [Full Text] [Related]  

  • 19. Differential expression and activity of matrix metalloproteinases during flow-modulated vein graft remodeling.
    Berceli SA; Jiang Z; Klingman NV; Pfahnl CL; Abouhamze ZS; Frase CD; Schultz GS; Ozaki CK
    J Vasc Surg; 2004 May; 39(5):1084-90. PubMed ID: 15111865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of osteopontin in the development of neointimal hyperplasia in vein grafts.
    Kang N; Ng CS; Hu J; Qiu ZB; Underwood MJ; Jeremy JY; Wan S
    Eur J Cardiothorac Surg; 2012 Jun; 41(6):1384-9. PubMed ID: 22219474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.